Urologia Internationalis Current Topics on Prostate Cancer Treatmentt (Urologia Internationalis, Vol 56, Suppl 1)
Read Online
Share

Urologia Internationalis Current Topics on Prostate Cancer Treatmentt (Urologia Internationalis, Vol 56, Suppl 1)

  • 934 Want to read
  • ·
  • 10 Currently reading

Published by S. Karger AG (Switzerland) .
Written in English

Subjects:

  • Oncology,
  • Urology & urogenital medicine,
  • Urology,
  • Prostate Cancer,
  • Medical / Nursing,
  • Health/Fitness

Book details:

The Physical Object
FormatPaperback
Number of Pages28
ID Numbers
Open LibraryOL12930588M
ISBN 103805563124
ISBN 109783805563123

Download Urologia Internationalis Current Topics on Prostate Cancer Treatmentt (Urologia Internationalis, Vol 56, Suppl 1)

PDF EPUB FB2 MOBI RTF

In a recent study, researchers examined real-world outcomes for patients with metastatic castration-resistant prostate cancer treated with radium (Xofigo). Study author Rana R. McKay, MD, of UC . Prostate cancer is cancer of the prostate gland. It is the second-leading cause of cancer death for men in the United States. About 1 in 35 men will die from it. Growths in the prostate can be benign (not . Why the Prostate Cancer Awareness program is a scam. The prostate cancer industry’s early prostate cancer detection-to-treatment program utilizing PSA-based screening of otherwise healthy men is a .   Dr. Peter Scardino's Prostate Book: The Complete Guide to Overcoming Prostate Cancer, Prostatitis and BPH [Scardino M.D., Peter T., Kelman, Judith] on *FREE* shipping on Reviews:

Prostate cancer treatment depends on a number of variables, including the aggressiveness of the cancer, how fast and how far it has spread, as well as a patient's overall health. Each treatment has side . Prostate specific antigen (PSA) is a protein produced by the prostate, measurable with a blood test, and high levels may indicate the presence of prostate cancer. However, since high levels can also indicate .   All prostate cancer treatments and their outcomes demand integration with the patient’s quality of life after treatment. Quality of life (QOL) issues represent the subjective interpretation of . Prostate cancer screening consists of 2 simple and quick tests: Prostate Specific Antigen (PSA) Test; PSA is a protein produced by the prostate and normally very small amounts are released into your .

The Prostate and Urologic Cancer Research Group conducts and supports research on prostate and bladder cancers, and new approaches to clinical prevention studies including cancer . Prostate cancer is the most common solid tumor in men. In , it is predicted that , new cases will be diagnosed. About one fifth of these patients will present with metastatic disease at the time of . Published Date: December Prostate cancer is the leading incident cancer among men, and population growth and aging have fueled a 40% rise in global case burden since 1,2 Despite .   The prostate cancer world is very different from the rest of the cancer world in one improtant area: The oncolgisist in most other cancers get involved up front. They are usually the 1st .